nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—autistic disorder	0.386	0.513	CbGaD
Clomipramine—SLC6A4—autistic disorder	0.207	0.275	CbGaD
Clomipramine—HTR2A—autistic disorder	0.159	0.211	CbGaD
Clomipramine—HTR2C—telencephalic ventricle—autistic disorder	0.00474	0.0572	CbGeAlD
Clomipramine—HTR2A—cerebellar cortex—autistic disorder	0.00408	0.0493	CbGeAlD
Clomipramine—HTR2A—pons—autistic disorder	0.00289	0.0349	CbGeAlD
Clomipramine—HTR2A—telencephalic ventricle—autistic disorder	0.00238	0.0287	CbGeAlD
Clomipramine—GSTP1—mouth—autistic disorder	0.00223	0.027	CbGeAlD
Clomipramine—HTR6—forebrain—autistic disorder	0.00214	0.0258	CbGeAlD
Clomipramine—SLC6A4—hindbrain—autistic disorder	0.00212	0.0256	CbGeAlD
Clomipramine—HTR6—telencephalon—autistic disorder	0.00197	0.0238	CbGeAlD
Clomipramine—GSTP1—eye—autistic disorder	0.00142	0.0172	CbGeAlD
Clomipramine—GSTP1—forebrain—autistic disorder	0.00141	0.017	CbGeAlD
Clomipramine—HRH2—digestive system—autistic disorder	0.00137	0.0166	CbGeAlD
Clomipramine—GSTP1—telencephalon—autistic disorder	0.0013	0.0156	CbGeAlD
Clomipramine—HTR2C—brainstem—autistic disorder	0.00128	0.0155	CbGeAlD
Clomipramine—HTR2C—forebrain—autistic disorder	0.00124	0.0149	CbGeAlD
Clomipramine—HTR6—head—autistic disorder	0.00123	0.0148	CbGeAlD
Clomipramine—SLC6A4—brainstem—autistic disorder	0.00121	0.0147	CbGeAlD
Clomipramine—SLC6A4—forebrain—autistic disorder	0.00117	0.0142	CbGeAlD
Clomipramine—HTR6—nervous system—autistic disorder	0.00116	0.014	CbGeAlD
Clomipramine—HTR2B—forebrain—autistic disorder	0.00116	0.014	CbGeAlD
Clomipramine—HTR2C—telencephalon—autistic disorder	0.00114	0.0137	CbGeAlD
Clomipramine—HTR2A—hindbrain—autistic disorder	0.00112	0.0135	CbGeAlD
Clomipramine—HRH2—head—autistic disorder	0.00112	0.0135	CbGeAlD
Clomipramine—HTR6—central nervous system—autistic disorder	0.00112	0.0135	CbGeAlD
Clomipramine—SLC6A4—telencephalon—autistic disorder	0.00108	0.013	CbGeAlD
Clomipramine—SLC6A2—brainstem—autistic disorder	0.00107	0.0129	CbGeAlD
Clomipramine—HTR2B—telencephalon—autistic disorder	0.00107	0.0129	CbGeAlD
Clomipramine—HRH2—nervous system—autistic disorder	0.00106	0.0128	CbGeAlD
Clomipramine—SLC6A2—forebrain—autistic disorder	0.00103	0.0125	CbGeAlD
Clomipramine—HRH2—central nervous system—autistic disorder	0.00102	0.0123	CbGeAlD
Clomipramine—CYP2D6—hindbrain—autistic disorder	0.00102	0.0123	CbGeAlD
Clomipramine—GSTP1—digestive system—autistic disorder	0.000989	0.0119	CbGeAlD
Clomipramine—SLC6A2—telencephalon—autistic disorder	0.000949	0.0115	CbGeAlD
Clomipramine—HTR6—brain—autistic disorder	0.000888	0.0107	CbGeAlD
Clomipramine—SLC6A4—digestive system—autistic disorder	0.000823	0.00994	CbGeAlD
Clomipramine—HTR2B—digestive system—autistic disorder	0.000815	0.00985	CbGeAlD
Clomipramine—HRH2—brain—autistic disorder	0.000812	0.0098	CbGeAlD
Clomipramine—GSTP1—head—autistic disorder	0.000807	0.00974	CbGeAlD
Clomipramine—GSTP1—nervous system—autistic disorder	0.000765	0.00923	CbGeAlD
Clomipramine—GSTP1—central nervous system—autistic disorder	0.000736	0.00889	CbGeAlD
Clomipramine—ADRA2A—forebrain—autistic disorder	0.00073	0.00881	CbGeAlD
Clomipramine—GSTP1—cerebellum—autistic disorder	0.00072	0.00869	CbGeAlD
Clomipramine—HTR2C—head—autistic disorder	0.000708	0.00855	CbGeAlD
Clomipramine—CYP2C19—digestive system—autistic disorder	0.000682	0.00823	CbGeAlD
Clomipramine—HTR2C—nervous system—autistic disorder	0.000671	0.00811	CbGeAlD
Clomipramine—SLC6A4—head—autistic disorder	0.000671	0.00811	CbGeAlD
Clomipramine—ADRA2A—telencephalon—autistic disorder	0.000671	0.0081	CbGeAlD
Clomipramine—HTR2B—head—autistic disorder	0.000665	0.00803	CbGeAlD
Clomipramine—HTR2C—central nervous system—autistic disorder	0.000646	0.0078	CbGeAlD
Clomipramine—HTR2A—brainstem—autistic disorder	0.000643	0.00776	CbGeAlD
Clomipramine—SLC6A4—nervous system—autistic disorder	0.000636	0.00768	CbGeAlD
Clomipramine—HTR2B—nervous system—autistic disorder	0.000631	0.00761	CbGeAlD
Clomipramine—HTR2A—eye—autistic disorder	0.000626	0.00756	CbGeAlD
Clomipramine—HTR2A—forebrain—autistic disorder	0.00062	0.00749	CbGeAlD
Clomipramine—SLC6A4—central nervous system—autistic disorder	0.000613	0.0074	CbGeAlD
Clomipramine—HTR2B—central nervous system—autistic disorder	0.000607	0.00733	CbGeAlD
Clomipramine—SLC6A2—head—autistic disorder	0.000591	0.00714	CbGeAlD
Clomipramine—CYP2D6—brainstem—autistic disorder	0.000586	0.00707	CbGeAlD
Clomipramine—GSTP1—brain—autistic disorder	0.000585	0.00706	CbGeAlD
Clomipramine—HTR2A—telencephalon—autistic disorder	0.00057	0.00689	CbGeAlD
Clomipramine—CYP2D6—forebrain—autistic disorder	0.000565	0.00682	CbGeAlD
Clomipramine—SLC6A2—nervous system—autistic disorder	0.00056	0.00677	CbGeAlD
Clomipramine—CYP1A2—digestive system—autistic disorder	0.000557	0.00672	CbGeAlD
Clomipramine—SLC6A2—central nervous system—autistic disorder	0.000539	0.00651	CbGeAlD
Clomipramine—CYP2D6—telencephalon—autistic disorder	0.00052	0.00627	CbGeAlD
Clomipramine—HTR2C—brain—autistic disorder	0.000513	0.0062	CbGeAlD
Clomipramine—ALB—brain—autistic disorder	0.000501	0.00604	CbGeAlD
Clomipramine—SLC6A4—brain—autistic disorder	0.000486	0.00587	CbGeAlD
Clomipramine—HTR2B—brain—autistic disorder	0.000482	0.00582	CbGeAlD
Clomipramine—HTR2A—digestive system—autistic disorder	0.000435	0.00526	CbGeAlD
Clomipramine—SLC6A2—brain—autistic disorder	0.000428	0.00517	CbGeAlD
Clomipramine—ADRA2A—head—autistic disorder	0.000418	0.00504	CbGeAlD
Clomipramine—ABCB1—forebrain—autistic disorder	0.000406	0.00491	CbGeAlD
Clomipramine—CYP3A4—digestive system—autistic disorder	0.000403	0.00487	CbGeAlD
Clomipramine—CYP2D6—digestive system—autistic disorder	0.000397	0.00479	CbGeAlD
Clomipramine—ADRA2A—nervous system—autistic disorder	0.000396	0.00478	CbGeAlD
Clomipramine—ADRA2A—central nervous system—autistic disorder	0.000381	0.0046	CbGeAlD
Clomipramine—ABCB1—telencephalon—autistic disorder	0.000374	0.00451	CbGeAlD
Clomipramine—ADRA2A—cerebellum—autistic disorder	0.000373	0.0045	CbGeAlD
Clomipramine—HTR2A—head—autistic disorder	0.000355	0.00429	CbGeAlD
Clomipramine—HTR2A—nervous system—autistic disorder	0.000337	0.00407	CbGeAlD
Clomipramine—HTR2A—central nervous system—autistic disorder	0.000324	0.00391	CbGeAlD
Clomipramine—CYP2D6—head—autistic disorder	0.000324	0.00391	CbGeAlD
Clomipramine—HTR2A—cerebellum—autistic disorder	0.000317	0.00383	CbGeAlD
Clomipramine—CYP3A4—nervous system—autistic disorder	0.000312	0.00376	CbGeAlD
Clomipramine—CYP2D6—nervous system—autistic disorder	0.000307	0.0037	CbGeAlD
Clomipramine—ADRA2A—brain—autistic disorder	0.000303	0.00366	CbGeAlD
Clomipramine—CYP3A4—central nervous system—autistic disorder	0.0003	0.00362	CbGeAlD
Clomipramine—CYP2D6—central nervous system—autistic disorder	0.000295	0.00357	CbGeAlD
Clomipramine—CYP2D6—cerebellum—autistic disorder	0.000289	0.00349	CbGeAlD
Clomipramine—ABCB1—digestive system—autistic disorder	0.000285	0.00345	CbGeAlD
Clomipramine—Amitriptyline—NTRK2—autistic disorder	0.000281	0.0313	CrCbGaD
Clomipramine—Adinazolam—GABRG3—autistic disorder	0.00028	0.0312	CrCbGaD
Clomipramine—HTR2A—brain—autistic disorder	0.000257	0.00311	CbGeAlD
Clomipramine—Flurazepam—GABRG3—autistic disorder	0.000252	0.0281	CrCbGaD
Clomipramine—CYP2D6—brain—autistic disorder	0.000234	0.00283	CbGeAlD
Clomipramine—ABCB1—head—autistic disorder	0.000233	0.00281	CbGeAlD
Clomipramine—ABCB1—nervous system—autistic disorder	0.000221	0.00266	CbGeAlD
Clomipramine—ABCB1—central nervous system—autistic disorder	0.000212	0.00257	CbGeAlD
Clomipramine—Adinazolam—GABRB1—autistic disorder	0.000209	0.0233	CrCbGaD
Clomipramine—ABCB1—cerebellum—autistic disorder	0.000208	0.00251	CbGeAlD
Clomipramine—Propericiazine—DRD1—autistic disorder	0.000207	0.023	CrCbGaD
Clomipramine—Diazepam—GABRG3—autistic disorder	0.0002	0.0223	CrCbGaD
Clomipramine—Adinazolam—GABRA4—autistic disorder	0.000195	0.0217	CrCbGaD
Clomipramine—Flurazepam—GABRB1—autistic disorder	0.000188	0.021	CrCbGaD
Clomipramine—Clobazam—GABRB2—autistic disorder	0.000186	0.0207	CrCbGaD
Clomipramine—Clobazam—GABRA1—autistic disorder	0.000183	0.0203	CrCbGaD
Clomipramine—Trifluoperazine—XDH—autistic disorder	0.000177	0.0197	CrCbGaD
Clomipramine—Flurazepam—GABRA4—autistic disorder	0.000176	0.0196	CrCbGaD
Clomipramine—Adinazolam—GABRA5—autistic disorder	0.000173	0.0193	CrCbGaD
Clomipramine—Adinazolam—GABRB3—autistic disorder	0.000173	0.0193	CrCbGaD
Clomipramine—Adinazolam—GABRA3—autistic disorder	0.00017	0.019	CrCbGaD
Clomipramine—ABCB1—brain—autistic disorder	0.000169	0.00204	CbGeAlD
Clomipramine—Trimipramine—HTR3A—autistic disorder	0.000166	0.0185	CrCbGaD
Clomipramine—Trimipramine—HTR1D—autistic disorder	0.000164	0.0183	CrCbGaD
Clomipramine—Flurazepam—GABRB3—autistic disorder	0.000156	0.0174	CrCbGaD
Clomipramine—Flurazepam—GABRA5—autistic disorder	0.000156	0.0174	CrCbGaD
Clomipramine—Flurazepam—GABRA3—autistic disorder	0.000153	0.0171	CrCbGaD
Clomipramine—Adinazolam—GABRB2—autistic disorder	0.000152	0.0169	CrCbGaD
Clomipramine—Diazepam—GABRB1—autistic disorder	0.00015	0.0167	CrCbGaD
Clomipramine—Adinazolam—GABRA1—autistic disorder	0.000149	0.0166	CrCbGaD
Clomipramine—Triflupromazine—DRD1—autistic disorder	0.000143	0.016	CrCbGaD
Clomipramine—Adinazolam—GABRA2—autistic disorder	0.000142	0.0159	CrCbGaD
Clomipramine—Flurazepam—GABRB2—autistic disorder	0.000137	0.0152	CrCbGaD
Clomipramine—Flurazepam—GABRA1—autistic disorder	0.000134	0.0149	CrCbGaD
Clomipramine—Acepromazine—DRD1—autistic disorder	0.000133	0.0148	CrCbGaD
Clomipramine—Thioproperazine—DRD1—autistic disorder	0.00013	0.0145	CrCbGaD
Clomipramine—Flurazepam—GABRA2—autistic disorder	0.000128	0.0143	CrCbGaD
Clomipramine—Pipotiazine—DRD1—autistic disorder	0.000128	0.0142	CrCbGaD
Clomipramine—Prochlorperazine—DRD3—autistic disorder	0.000124	0.0138	CrCbGaD
Clomipramine—Diazepam—GABRA5—autistic disorder	0.000124	0.0138	CrCbGaD
Clomipramine—Diazepam—GABRB3—autistic disorder	0.000124	0.0138	CrCbGaD
Clomipramine—Diazepam—GABRA3—autistic disorder	0.000122	0.0136	CrCbGaD
Clomipramine—Amitriptyline—HTR1D—autistic disorder	0.000121	0.0135	CrCbGaD
Clomipramine—Cyamemazine—HTR2A—autistic disorder	0.000113	0.0125	CrCbGaD
Clomipramine—Diazepam—GABRB2—autistic disorder	0.000109	0.0121	CrCbGaD
Clomipramine—Diazepam—GABRA1—autistic disorder	0.000107	0.0119	CrCbGaD
Clomipramine—Propiomazine—DRD1—autistic disorder	0.000106	0.0118	CrCbGaD
Clomipramine—Chlorprothixene—DRD3—autistic disorder	0.000102	0.0114	CrCbGaD
Clomipramine—Diazepam—GABRA2—autistic disorder	0.000102	0.0114	CrCbGaD
Clomipramine—Chlorprothixene—DRD1—autistic disorder	0.0001	0.0112	CrCbGaD
Clomipramine—Chlorphenamine—SLC6A4—autistic disorder	9.53e-05	0.0106	CrCbGaD
Clomipramine—Thioridazine—DRD1—autistic disorder	9.51e-05	0.0106	CrCbGaD
Clomipramine—Methotrimeprazine—DRD3—autistic disorder	9.25e-05	0.0103	CrCbGaD
Clomipramine—Methotrimeprazine—DRD1—autistic disorder	9.08e-05	0.0101	CrCbGaD
Clomipramine—Amitriptyline—OPRM1—autistic disorder	8.81e-05	0.00981	CrCbGaD
Clomipramine—Perphenazine—DRD1—autistic disorder	8.73e-05	0.00972	CrCbGaD
Clomipramine—Promazine—DRD1—autistic disorder	7.87e-05	0.00876	CrCbGaD
Clomipramine—Acepromazine—HTR2A—autistic disorder	7.23e-05	0.00806	CrCbGaD
Clomipramine—Amitriptyline—HTR1B—autistic disorder	7.18e-05	0.008	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—autistic disorder	7.07e-05	0.00788	CrCbGaD
Clomipramine—Chlorpromazine—DRD3—autistic disorder	7.05e-05	0.00786	CrCbGaD
Clomipramine—Nortriptyline—SLC6A4—autistic disorder	6.99e-05	0.00779	CrCbGaD
Clomipramine—Amitriptyline—DRD3—autistic disorder	6.97e-05	0.00777	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—autistic disorder	6.96e-05	0.00775	CrCbGaD
Clomipramine—Chlorpromazine—DRD1—autistic disorder	6.92e-05	0.00771	CrCbGaD
Clomipramine—Trimipramine—SLC6A4—autistic disorder	6.58e-05	0.00733	CrCbGaD
Clomipramine—Desipramine—ADRB2—autistic disorder	6.34e-05	0.00706	CrCbGaD
Clomipramine—Doxepin—SLC6A4—autistic disorder	6.27e-05	0.00699	CrCbGaD
Clomipramine—Propiomazine—HTR2A—autistic disorder	5.78e-05	0.00644	CrCbGaD
Clomipramine—Desipramine—SLC6A4—autistic disorder	5.76e-05	0.00641	CrCbGaD
Clomipramine—Chlorprothixene—HTR2A—autistic disorder	5.47e-05	0.0061	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—autistic disorder	5.37e-05	0.00599	CrCbGaD
Clomipramine—Thioridazine—HTR2A—autistic disorder	5.18e-05	0.00577	CrCbGaD
Clomipramine—Trimipramine—HTR2A—autistic disorder	5.06e-05	0.00564	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—autistic disorder	4.94e-05	0.00551	CrCbGaD
Clomipramine—Imipramine—SLC6A4—autistic disorder	4.88e-05	0.00544	CrCbGaD
Clomipramine—Promethazine—HTR2A—autistic disorder	4.87e-05	0.00543	CrCbGaD
Clomipramine—Amitriptyline—SLC6A4—autistic disorder	4.85e-05	0.00541	CrCbGaD
Clomipramine—Doxepin—HTR2A—autistic disorder	4.82e-05	0.00537	CrCbGaD
Clomipramine—Trifluoperazine—HTR2A—autistic disorder	4.81e-05	0.00535	CrCbGaD
Clomipramine—Perphenazine—HTR2A—autistic disorder	4.75e-05	0.0053	CrCbGaD
Clomipramine—Desipramine—HTR2A—autistic disorder	4.42e-05	0.00493	CrCbGaD
Clomipramine—Promazine—HTR2A—autistic disorder	4.29e-05	0.00477	CrCbGaD
Clomipramine—Chlorpromazine—HTR2A—autistic disorder	3.77e-05	0.0042	CrCbGaD
Clomipramine—Imipramine—HTR2A—autistic disorder	3.75e-05	0.00418	CrCbGaD
Clomipramine—Amitriptyline—HTR2A—autistic disorder	3.73e-05	0.00415	CrCbGaD
Clomipramine—ADRA2A—Metabolism—COMT—autistic disorder	8.3e-06	5.32e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADSL—autistic disorder	8.28e-06	5.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTP1—autistic disorder	8.26e-06	5.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MAOA—autistic disorder	8.24e-06	5.28e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—LEP—autistic disorder	8.19e-06	5.25e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APOE—autistic disorder	8.19e-06	5.25e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CACNA1C—autistic disorder	8.16e-06	5.23e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MAOB—autistic disorder	8.13e-06	5.21e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—XDH—autistic disorder	8.12e-06	5.2e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APC—autistic disorder	8.1e-06	5.19e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CG—autistic disorder	8.1e-06	5.19e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—DHFR—autistic disorder	8.07e-06	5.17e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CAT—autistic disorder	8.04e-06	5.15e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PLA2G4A—autistic disorder	8.03e-06	5.15e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGF—autistic disorder	8.01e-06	5.13e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CG—autistic disorder	7.98e-06	5.11e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—STX1A—autistic disorder	7.97e-06	5.11e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NPAS2—autistic disorder	7.97e-06	5.11e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRB2—autistic disorder	7.9e-06	5.06e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—DHFR—autistic disorder	7.88e-06	5.05e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL2—autistic disorder	7.83e-06	5.01e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MEF2C—autistic disorder	7.81e-06	5.01e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	7.74e-06	4.96e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRAS—autistic disorder	7.73e-06	4.95e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PRKCB—autistic disorder	7.73e-06	4.95e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL2—autistic disorder	7.72e-06	4.95e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—POMC—autistic disorder	7.71e-06	4.94e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TCN2—autistic disorder	7.7e-06	4.93e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ITGB3—autistic disorder	7.62e-06	4.88e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—POMC—autistic disorder	7.59e-06	4.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PLA2G4A—autistic disorder	7.59e-06	4.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTM1—autistic disorder	7.59e-06	4.86e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.58e-06	4.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRL—autistic disorder	7.57e-06	4.85e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TPH2—autistic disorder	7.56e-06	4.84e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—MAPK1—autistic disorder	7.48e-06	4.79e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DPYD—autistic disorder	7.44e-06	4.77e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL2—autistic disorder	7.43e-06	4.76e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—DHFR—autistic disorder	7.43e-06	4.76e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AVP—autistic disorder	7.42e-06	4.75e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1—autistic disorder	7.42e-06	4.75e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—autistic disorder	7.4e-06	4.74e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APC—autistic disorder	7.39e-06	4.74e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CG—autistic disorder	7.39e-06	4.74e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF2—autistic disorder	7.39e-06	4.73e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—MAPK1—autistic disorder	7.38e-06	4.73e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADA—autistic disorder	7.35e-06	4.71e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGF—autistic disorder	7.31e-06	4.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX1—autistic disorder	7.27e-06	4.66e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADRB2—autistic disorder	7.19e-06	4.6e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—autistic disorder	7.11e-06	4.55e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2—autistic disorder	7.11e-06	4.55e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP19A1—autistic disorder	7.05e-06	4.51e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SERPINE1—autistic disorder	7.04e-06	4.51e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—autistic disorder	7.04e-06	4.51e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTEN—autistic disorder	6.99e-06	4.48e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	6.99e-06	4.48e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PLA2G4A—autistic disorder	6.98e-06	4.47e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CACNA1C—autistic disorder	6.92e-06	4.43e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	6.81e-06	4.36e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2—autistic disorder	6.8e-06	4.35e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MEF2C—autistic disorder	6.79e-06	4.35e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1—autistic disorder	6.77e-06	4.34e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSC2—autistic disorder	6.75e-06	4.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AVP—autistic disorder	6.75e-06	4.32e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MAPK1—autistic disorder	6.74e-06	4.32e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF2—autistic disorder	6.72e-06	4.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MTHFR—autistic disorder	6.71e-06	4.3e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RORA—autistic disorder	6.7e-06	4.29e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	6.65e-06	4.26e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ITGB3—autistic disorder	6.61e-06	4.24e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.61e-06	4.24e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—LEP—autistic disorder	6.61e-06	4.23e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—autistic disorder	6.61e-06	4.23e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—COMT—autistic disorder	6.55e-06	4.2e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTP1—autistic disorder	6.52e-06	4.18e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MAOA—autistic disorder	6.5e-06	4.17e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SERPINE1—autistic disorder	6.43e-06	4.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	6.35e-06	4.07e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CAT—autistic disorder	6.34e-06	4.06e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP19A1—autistic disorder	6.32e-06	4.05e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DHFR—autistic disorder	6.29e-06	4.03e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MAOB—autistic disorder	6.28e-06	4.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—autistic disorder	6.24e-06	4e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PRKCB—autistic disorder	6.23e-06	3.99e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	6.18e-06	3.96e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	6.17e-06	3.96e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP19A1—autistic disorder	6.17e-06	3.95e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2—autistic disorder	6.17e-06	3.95e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	6.02e-06	3.85e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HRAS—autistic disorder	6.01e-06	3.85e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PLA2G4A—autistic disorder	5.99e-06	3.84e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTM1—autistic disorder	5.99e-06	3.84e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APC—autistic disorder	5.97e-06	3.82e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CG—autistic disorder	5.97e-06	3.82e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.94e-06	3.8e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRAS—autistic disorder	5.93e-06	3.8e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MAPK1—autistic disorder	5.91e-06	3.78e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGF—autistic disorder	5.9e-06	3.78e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—COMT—autistic disorder	5.88e-06	3.77e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSC2—autistic disorder	5.87e-06	3.76e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTP1—autistic disorder	5.85e-06	3.75e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MAOA—autistic disorder	5.84e-06	3.74e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TPH2—autistic disorder	5.84e-06	3.74e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP19A1—autistic disorder	5.82e-06	3.73e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DPYD—autistic disorder	5.74e-06	3.68e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—LEP—autistic disorder	5.74e-06	3.68e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—autistic disorder	5.74e-06	3.68e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—COMT—autistic disorder	5.74e-06	3.68e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX1—autistic disorder	5.74e-06	3.67e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTP1—autistic disorder	5.71e-06	3.66e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2—autistic disorder	5.7e-06	3.65e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MAOA—autistic disorder	5.7e-06	3.65e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CAT—autistic disorder	5.69e-06	3.65e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK1—autistic disorder	5.69e-06	3.64e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—autistic disorder	5.68e-06	3.64e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—autistic disorder	5.67e-06	3.63e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CG—autistic disorder	5.64e-06	3.61e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	5.62e-06	3.6e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2—autistic disorder	5.61e-06	3.6e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CAT—autistic disorder	5.56e-06	3.56e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1—autistic disorder	5.46e-06	3.5e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	5.44e-06	3.48e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKCB—autistic disorder	5.41e-06	3.47e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—autistic disorder	5.41e-06	3.47e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—COMT—autistic disorder	5.41e-06	3.46e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—autistic disorder	5.38e-06	3.45e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—autistic disorder	5.38e-06	3.44e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PLA2G4A—autistic disorder	5.38e-06	3.44e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MAOA—autistic disorder	5.37e-06	3.44e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—autistic disorder	5.36e-06	3.44e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTEN—autistic disorder	5.36e-06	3.44e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CACNA1C—autistic disorder	5.34e-06	3.42e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSC2—autistic disorder	5.34e-06	3.42e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	5.3e-06	3.4e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—autistic disorder	5.29e-06	3.39e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PLA2G4A—autistic disorder	5.25e-06	3.36e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—autistic disorder	5.25e-06	3.36e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAT—autistic disorder	5.24e-06	3.36e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—LEP—autistic disorder	5.22e-06	3.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—autistic disorder	5.22e-06	3.35e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2—autistic disorder	5.2e-06	3.33e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	5.19e-06	3.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	5.18e-06	3.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APC—autistic disorder	5.18e-06	3.32e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—autistic disorder	5.18e-06	3.32e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—autistic disorder	5.15e-06	3.3e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGF—autistic disorder	5.12e-06	3.28e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—autistic disorder	5.03e-06	3.22e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	4.95e-06	3.17e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—autistic disorder	4.95e-06	3.17e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—autistic disorder	4.93e-06	3.16e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—autistic disorder	4.93e-06	3.16e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP19A1—autistic disorder	4.93e-06	3.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	4.92e-06	3.15e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTEN—autistic disorder	4.9e-06	3.14e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DHFR—autistic disorder	4.86e-06	3.11e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—autistic disorder	4.75e-06	3.04e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—autistic disorder	4.74e-06	3.04e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—autistic disorder	4.74e-06	3.04e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—autistic disorder	4.74e-06	3.03e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	4.72e-06	3.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APC—autistic disorder	4.71e-06	3.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	4.71e-06	3.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGF—autistic disorder	4.66e-06	2.98e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—autistic disorder	4.64e-06	2.97e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.63e-06	2.96e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—COMT—autistic disorder	4.58e-06	2.93e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—autistic disorder	4.56e-06	2.92e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—autistic disorder	4.56e-06	2.92e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MAOA—autistic disorder	4.55e-06	2.91e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	4.5e-06	2.89e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—autistic disorder	4.49e-06	2.87e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CG—autistic disorder	4.45e-06	2.85e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAT—autistic disorder	4.44e-06	2.84e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—autistic disorder	4.42e-06	2.83e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—autistic disorder	4.37e-06	2.8e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—autistic disorder	4.37e-06	2.8e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—autistic disorder	4.36e-06	2.8e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—autistic disorder	4.36e-06	2.79e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—autistic disorder	4.32e-06	2.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—autistic disorder	4.31e-06	2.76e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	4.29e-06	2.75e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—autistic disorder	4.28e-06	2.74e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—autistic disorder	4.23e-06	2.71e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—autistic disorder	4.2e-06	2.69e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—autistic disorder	4.19e-06	2.68e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PLA2G4A—autistic disorder	4.19e-06	2.68e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—autistic disorder	4.18e-06	2.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	4.1e-06	2.63e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—autistic disorder	4.07e-06	2.61e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—autistic disorder	4.01e-06	2.57e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CG—autistic disorder	3.99e-06	2.56e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—autistic disorder	3.98e-06	2.55e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—autistic disorder	3.95e-06	2.53e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CG—autistic disorder	3.9e-06	2.5e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.8e-06	2.44e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—autistic disorder	3.8e-06	2.43e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—autistic disorder	3.79e-06	2.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—autistic disorder	3.73e-06	2.39e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—autistic disorder	3.71e-06	2.38e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—autistic disorder	3.7e-06	2.37e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.67e-06	2.35e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—autistic disorder	3.65e-06	2.34e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—autistic disorder	3.63e-06	2.32e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—COMT—autistic disorder	3.54e-06	2.26e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—autistic disorder	3.52e-06	2.25e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MAOA—autistic disorder	3.51e-06	2.25e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—autistic disorder	3.5e-06	2.24e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—autistic disorder	3.5e-06	2.24e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	3.45e-06	2.21e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—autistic disorder	3.45e-06	2.21e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—autistic disorder	3.43e-06	2.2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAT—autistic disorder	3.42e-06	2.19e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—autistic disorder	3.38e-06	2.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—autistic disorder	3.35e-06	2.15e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—autistic disorder	3.32e-06	2.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—autistic disorder	3.3e-06	2.11e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.23e-06	2.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—autistic disorder	3.23e-06	2.07e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—autistic disorder	3.21e-06	2.06e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—autistic disorder	3.2e-06	2.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—autistic disorder	3.12e-06	2e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CG—autistic disorder	3.11e-06	1.99e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—autistic disorder	3.1e-06	1.98e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—autistic disorder	3.06e-06	1.96e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—autistic disorder	3.03e-06	1.94e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—autistic disorder	2.96e-06	1.9e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—autistic disorder	2.96e-06	1.9e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—autistic disorder	2.95e-06	1.89e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—autistic disorder	2.86e-06	1.83e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—autistic disorder	2.79e-06	1.79e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—autistic disorder	2.79e-06	1.79e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—autistic disorder	2.66e-06	1.7e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—autistic disorder	2.64e-06	1.69e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—autistic disorder	2.58e-06	1.65e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—autistic disorder	2.58e-06	1.65e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	2.54e-06	1.63e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—autistic disorder	2.47e-06	1.58e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—autistic disorder	2.43e-06	1.56e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.4e-06	1.54e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—autistic disorder	2.36e-06	1.51e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—autistic disorder	2.29e-06	1.46e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—autistic disorder	2.24e-06	1.43e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—autistic disorder	2.14e-06	1.37e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—autistic disorder	2.06e-06	1.32e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—autistic disorder	2.04e-06	1.3e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—autistic disorder	1.95e-06	1.25e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—autistic disorder	1.82e-06	1.17e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—autistic disorder	1.59e-06	1.02e-05	CbGpPWpGaD
